Selumetinib (Sel) and cisplatin/gemcitabine (CisGem) for advanced biliary tract cancer (BTC): A randomized trial.

被引：3
|
作者：
Doherty, Mark
Tam, Vincent C.
McNamara, Mairead Geraldine
Hedley, David W.
Dhani, Neesha C.
Chen, Eric Xueyu
Jang, Raymond Woo-Jun
Tang, Patricia A.
Sim, Hao-Wen
O'Kane, Grainne M.
DeLuca, Stephanie
Wang, Lisa
Brooks, Kelly
Knox, Jennifer J.
机构：
[1] Univ Hlth Network, Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[3] Christie NHS Fdn Trust, Christie Hosp, Manchester, Lancs, England
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr Pharm, Toronto, ON, Canada
[7] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4084
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Economic evaluation for the US of durvalumab plus gemcitabine and cisplatin (DGC) in advanced biliary tract cancer (BTC)
    Aqel, Osama
    Shen, Yunrong
    Alfayoumi, Ibrahim
    Abraham, Ivo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] ABC-04: A phase 1b trial of cisplatin, gemcitabine, and selumetinib in patients with advanced biliary tract cancer.
    Bridgewater, John A.
    Beare, Sandy
    Dymphna, Lee
    Lopes, Andre
    Duggan, Marian
    Wasan, Harpreet S.
    Valle, Juan W.
    McEntee, Delyth
    Ricamara, Marivic
    Sukumaran, Ajithkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A phase II trial of gemcitabine plus cisplatin (GP) in patients with inoperable biliary tract cancer (BTC).
    Park, JO
    Kang, WK
    Kim, TY
    Lee, MA
    Ahn, MJ
    Kim, HK
    Lee, NS
    Lim, HY
    Park, BJ
    Kim, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 341S - 341S
  • [4] Efficacy and safety of FOLFIRINOX in advanced biliary tract cancer after failure of gemcitabine plus cisplatin: A phase II trial.
    Belkouz, Ali
    de Vos-Geelen, Judith
    Eskens, Ferry
    Mathot, Ron A. A.
    van Gulik, Thomas
    van Oijen, Martijn G. H.
    Punt, Cornelis J. A.
    Wilmink, Johanna
    Kluempen, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer
    Ahn, Daniel H.
    Reardon, Josh
    Ahn, Chul W.
    Bupathi, Manojkumar
    Mikhail, Sameh
    Wu, Christina Sing-Ying
    Bekaii-Saab, Tanios
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (08) : 1671 - 1675
  • [6] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
    Markussen, Alice
    Jensen, Lars Henrik
    Diness, Laura Vittrup
    Larsen, Finn Ole
    CANCERS, 2020, 12 (07) : 1 - 10
  • [7] Cadonilimab in combined with gemcitabine and cisplatin in advanced biliary tract cancer (BicureX): A phase II, single-arm clinical trial.
    Ma, Ji
    Wang, Tao
    Chen, Yidi
    Yang, Yi
    Qiu, Yiwen
    Shen, Shu
    Yi, Cheng
    Wang, Wentao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer
    Park, Jin Myung
    Ryu, Ji Kon
    Paik, Woo Hyun
    Song, Byeong Jun
    Park, Joo Kyung
    Kim, Yong-Tae
    Yoon, Yong Bum
    GASTROENTEROLOGY, 2013, 144 (05) : S529 - S529
  • [9] Cisplatin and gemcitabine for advanced biliary tract cancer: A meta-analysis of two randomized trials
    Mizuno, Nobumasa
    Valle, Juan W.
    Furuse, Junji
    Jitlal, Mark
    Beare, Sandy
    Wasan, Harpreet
    Bridgewater, John A.
    Okusaka, Takuji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] ABC-03: A randomized phase II trial of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine (CisGem) chemotherapy for patients (pts) with advanced biliary tract cancer (ABC).
    Valle, Juan W.
    Wasan, Harpreet
    Jitlal, Mark
    Backen, Alison Catherine
    Palmer, Daniel H.
    Duggan, Marian
    Cunningham, David
    Anthoney, David Alan
    Corrie, Philippa
    Madhusudan, Srinivasan
    Maraveyas, Anthony
    Ross, Paul J.
    Waters, Justin S.
    Steward, William P.
    Rees, Charlotte
    Beare, Sandy
    Dive, Caroline
    Bridgewater, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345